Shanghai Auzone Biological Technology Co., Ltd.

This study tests a new tablet called TTYP01 in people with early Alzheimer's (mild memory problems or mild dementia). About 180 participants will receive either a low dose, high dose, or placebo for 78 weeks. The goal is to see if the drug can slow down memory decline and reduce …